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Squamous Cell Lung Carcinoma Presenting  
with Erythema Annulare Centrifugum
Erythema annulare centrifugum (EAC) is a perma-
nent or migrating eruption characterized by annular, 
arcuate, or polycyclic erythematous lesions that ex-
pand to the periphery when the medial parts fade. 
Darier was the first to described it in 1916 (1,2). Defin-
ing the incidence and prevalence of EAC is difficult 
because the literature mostly consists of case reports 
and brief reviews. Although its etiology is not known 
for certain, it is assumed to be hypersensitivity reac-
tion to malignancies, infections, and drugs. However, 
there have not been any underlying factors detected 
in the majority of cases. The prognosis for EAC is ex-
cellent, except when associated with an underlying 
malignancy and other systemic disease (1-3). A diag-
nosis of EAC should be followed by diagnostic work-
up because it may result in discovery of an underlying 
disease.
We describe a 52-year-old man affected by EAC, 
who upon further examination was diagnosed with 
squamous cell carcinoma of the lung (SCCL).
A 52-year-old male patient was admitted to our 
department with itchy, erythematous, annular, poly-
cyclic plaques, with a trailing scale present on the 
inner aspect of the advancing edges (Figs. 1 and 2). 
The plaques had been present on his trunk, extremi-
ties, and face for more than 3 months. The patient 
reported that the itchy lesions had first appeared on 
his forearms, then spread to his trunk, lower extremi-
ties, and face in a few weeks. Skin punch biopsy re-
vealed orthokeratotic, parakeratotic hyperkeratosis 
observed occasionally on the epidermis, and mild 
vascular proliferation and perivascular mononuclear 
cell infiltration on the papillary dermis. The deep 
dermis, subcutis, and epidermal appendages were 
normal. The patient was diagnosed as EAC based on 
histopathologic and clinical findings. There was no 
history of antecedent infections or recent initiation of 
a new drug. Routine blood count and other chemis-
try tests produced normal results. Chest x-ray showed 
changes in the paracardiac areas of the middle and 
lower zones of the left lung, nodular opacities with 
peripheral reticulolinear extensions, and tubular ra-
diolucent areas compatible with bronchiectasis in 
this region (Fig. 3). Thoracic computed tomography 
scan revealed a thick-walled, cavitary lesion, 4.5 cm 
in diameter, centrally located in the suprahilar region 
of the upper lobe of the left lung, observed to have a 
subsidiary of the upper lobe bronchus, micronodules 
and branching linear opacities on the parenchyma, 
intra-interlobular irregular septal thickening, and 
tractional bronchiectasis with pleuroparenchymal 
density increments in peripheral areas (Fig. 4). In con-
Figures 1 and 2. Itchy, erythematous, annular, polycyclic plaques, with a trailing scale present on the 
inner aspect of the advancing edges.
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sultation with pulmonologist, the patient was diag-
nosed with lung cancer; laboratory findings: CA 15-3, 
32.7 U/mL (reference range: 0-31.3); CEA 7.75 ng/mL 
(reference range:  0-3); and erythrocyte sedimentation 
rate 21 mm/h (reference range:  0-15).
The patient was hospitalized for treatment at de-
partment of pulmonary disease. Tumorous cells were 
observed on histopathologic examination of the lung 
biopsy obtained during bronchoscopy, which stained 
positive for P63 and negative for CYT7-20, CEA, TTF1, 
and MUC31. 
Clinical and histopathologic findings, and in con-
sultation with a pulmonologist, indicated SCCL pre-
sented with superficial EAC. The patient was referred 
to thoracic surgery department for surgical treat-
ment.
Erythema annulare centrifugum is among dis-
eases of unknown etiology (4). Erythema giratum re-
pens and EAC are figure erythemas associated with 
malignancy (5). A review of medical literature reveals 
that malignancies related to EAC are squamous cell 
carcinoma, nasopharyngeal carcinoma, acute myelo-
cytic leukemia, peritoneal carcinomatosis, primary 
bronchial carcinoid, Hodgkin’s lymphoma, chronic 
lymphocytic leukemia, multiple myeloma, prostate 
carcinoma, malignant histiocytosis, mucinous ovar-
ian carcinoma, and breast cancer (3,4,6-9). Monsieur 
et al. report on EAC, pulmonary osteoarthropathy, 
palmoplantar hyperkeratosis, inappropriate secre-
tion of antidiuretic hormone, ectopic secretion of ad-
renocorticotropic hormone and calcitonin in poorly 
differentiated lung adenocarcinoma (10). Some other 
publications also report on a random relationship of 
EAC and malignancy (4). One study of 66 cases identi-
fied cutaneous fungal infection as the most important 
etiologic factor (72%), while other causes included 
benign internal neoplasm (13%), skin diseases (18%) 
and internal diseases (21%) (11). A study involving 73 
EAC patients revealed neoplasia in 7% of deep type 
EAC cases (12). 
Squamous cell carcinoma of the lung accounts for 
25%-30% of all lung cancers. Most lung carcinomas 
are diagnosed at an advanced stage, conferring a 
poor prognosis. The need to diagnose lung cancer at 
an early and potentially curable stage is thus obvious. 
Approximately 7%-10% of patients with lung cancer 
are asymptomatic, and their cancers are diagnosed 
incidentally after a chest radiograph performed for 
other reasons. Paraneoplastic syndromes may be the 
first or most prominent manifestation. Most paraneo-
plastic syndromes are caused by small cell lung can-
cer (SCLC). However, many paraneoplastic syndromes 
also occur in non-small cell lung cancer (NSCLC) pa-
tients. The symptoms may be endocrine, neuromus-
cular, musculoskeletal, cardiovascular, cutaneous, he-
matologic, gastrointestinal, renal, or miscellaneous in 
nature. Cutaneous itching is the most frequent cuta-
neous manifestation in patients with cancer. Herpes 
zoster, ichthyosis, flushes, alopecia, acanthosis nigri-
cans, dermic melanosis, or hypertrichosis may also 
Figure 3. Changes in the paracardiac areas of the middle 
and lower zones of the left lung, nodular opacities with pe-
ripheral reticulolinear extensions, and tubular radiolucent 
areas compatible with bronchiectasis.
Figure 4. A thick-walled, cavitary lesion centrally located in 
the suprahilar region of the upper lobe of the left lung, with 
a subsidiary of the upper lobe bronchus, micronodules and 
branching linear opacities on the parenchyma, intra-inter-
lobular irregular septal thickening, and tractional bronchi-
ectasis with pleuroparenchymal density increments in pe-
ripheral areas.
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be observed. When a patient is diagnosed as a “typi-
cal” paraneoplastic syndrome, a diagnosis of cancer 
should be considered and investigated (13).
Although our patient did not have any symptoms 
of lung carcinoma, etiologic study of EAC revealed 
early stages of SCCL. To our knowledge, this is the first 
case of EAC presented with SCCL. Etiology oriented 
research performed in EAC patients will help in early 
diagnosis and treatment of malignancies. This report 
is presented to emphasize the importance of etiolog-
ic research of EAC and EAC association with SCCL.
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